"10.1371_journal.pone.0074744","plos one","2013-10-11T00:00:00Z","Siok-Keen Tey; Glen A Kennedy; Deborah Cromer; Miles P Davenport; Susan Walker; Linda I Jones; Tania Crough; Simon T Durrant; James A Morton; Jason P Butler; Ashish K Misra; Geoffrey R Hill; Rajiv Khanna","Australian Centre for Vaccine Development and Tumour Immunology Laboratory, Queensland Institute of Medical Research, Herston, Queensland, Australia; Department of Haematology and Bone Marrow Transplantation, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia; Bone Marrow Transplant Laboratory, Queensland Institute of Medical Research, Herston, Queensland, Australia; School of Medicine, University of Queensland, Herston, Queensland, Australia; Complex Systems in Biology Group, Centre for Vascular Research, University of New South Wales, Kensington, New South Wales, Australia","Conceived and designed the experiments: SKT GRH RK. Analyzed the data: SKT DC MPD RK. Wrote the paper: SKT RK. Responsible for the recruitment of patients and clinical monitoring: SKT GAK STD AJM JPB AKM GRH. Performed various experimental assays for this study: SKT SW TC LIJ.","RK holds an international patent on CMV epitopes, which are included in the QuantiFERON-CMV kit. These epitopes are licensed to Cellestis Inc. for their inclusion in the QuantiFERON-CMV kit. International Patent on Human Cytomegalovirus Immunotherapy (Inventors listed: R. KHANNA), granted and maintained in the USA (patent No. 7524503), Australia (No. 2002312654), Japan (No. 4574166) and under application in Europe (EP02737666.4). In addition, RK has also acted as a consultant for Cellestis Inc. for the development of QuantiFERON-CMV assay. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","10","Siok-Keen Tey","SKT",13,TRUE,3,4,4,2,TRUE,TRUE,TRUE,1,"9",FALSE
